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Background: The effects of body mass index (BMI) on the prognosis of acute respiratory distress syndrome (ARDS)
are controversial. We aimed to further determine the relationship between BMI and the acute outcomes of patients
with ARDS.
Methods: We searched the Pubmed, Embase, Medline, Cochrane Central Register of Controlled Trials (CENTRAL),
and ISI Web of Science for trials published between 1946 and July 2016, using “BMI” or “body mass index” or
“overweight” or “obese” and “ARDS” or “ALI” or “acute respiratory distress syndrome” or “acute lung injury”,
without limitations on publication type or language. Heterogeneity and sensitivity analyses were conducted,
and a random-effects model was applied to calculate the odds ratio (OR) or mean difference (MD). Review
Manager (RevMan) was used to test the hypothesis using the Mann-Whitney U test. The primary outcome
was unadjusted mortality, and secondary outcomes included mechanical ventilation (MV)-free days and length
of stay (LOS) in the intensive care unit (ICU) and in hospital.
Results: Five trials with a total of 6268 patients were pooled in our final analysis. There was statistical heterogeneity
between normal-weight and overweight patients in LOS in the ICU (I2 = 71%, χ2 = 10.27, P = 0.02) and in MV-free days
(I2 = 89%, χ2 = 18.45, P < 0.0001). Compared with normal weight, being underweight was associated with higher
mortality (OR 1.59, 95% confidence interval (CI) 1.22, 2.08, P = 0.0006), while obesity and morbid obesity were more
likely to result in lower mortality (OR 0.68, 95% CI 0.57, 0.80, P < 0.00001; OR 0.72, 95% CI 0.56, 0.93, P = 0.01). MV-free
days were much longer in patients with morbid obesity (MD 2.64, 95% CI 0.60, 4.67, P = 0.01), but ICU and hospital LOS
were not influenced by BMI. An important limitation of our analysis is the lack of adjustment for age, sex, illness
severity, comorbid illness, and interaction of outcome parameters.
Conclusions: Obesity and morbid obesity are associated with lower mortality in patients with ARDS.
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Acute respiratory distress syndrome (ARDS) is an acute,
diffuse, and inflammatory lung injury that leads to in-
creased pulmonary vascular permeability, increased lung
weight, and loss of aerated tissue [1]. Clinical hallmarks of
ARDS are hypoxemia and bilateral radiographic opacities,
which result from the pathogenesis of diffuse alveolar
damage. It was first described in 1967 as a life-threatening
organ failure due to several pulmonary and extrapulmon-
ary injuries with an incidence of 86.2 per 100,000 patient
years and in-hospital mortality of up to 40% [2]. Despite
intense investigations and numerous large-scale clinical
trials, no specific therapies or medications have yet been
developed. Although various processes of care interven-
tions, such as lung-protective ventilation, prone position-
ing, and neuromuscular blockade, are proposed to be of
potential benefit, mortality still remains as high as 31%
[3–5]. Thus, prognostic predictors of ARDS may exert a
role in helping clinicians to evaluate disease severity and
make optimal treatment decisions.
Body mass index (BMI) is one of the common clinical
demographic characteristics and can be calculated from the
ratio of body weight to squared height (kg/m2). According
to the definition of the National Institutes of Health (NIH),
obesity can be classified into different categories on the
basis of BMI: overweight (BMI ≥25 to <30 kg/m2), obese
(BMI ≥30 to <40 kg/m2), or morbidly obese (BMI ≥40 kg/
m2), compared to normal weight (BMI ≥18.5 < 25 kg/m2)
and underweight (BMI <18.5 kg/m2) [6, 7]. In the USA, it
was reported that at least 25% of adults in the intensive care
unit (ICU) were overweight, obese, or morbidly obese, and
that this proportion was increasing [8]. Obesity is associ-
ated with increased morbidity in cardiovascular disease,
diabetes mellitus, and depression [9–11], which eventually
leads to more than 110,000 obesity-related excess deaths
annually [12] and estimated healthcare costs representing
5.7% of national health expenditure in the USA.
Pepper and colleagues report that among critically ill
patients with sepsis or septic shock, patients who are
overweight or obese according to BMI may have reduced
risk of mortality [13]. In patients with traumatic brain
injury, however, obesity tends to be associated with more
complications and greater mortality [14]. Similarly, there
have been controversial results in patients with ARDS in
different trials. Hence, a pooled analysis of the effects of
BMI on the prognosis of ARDS is warranted. Therefore,
we conducted a meta-analysis of all published trials,
aiming to identify the relationship between BMI and the
acute outcomes of patients with ARDS.
Methods
Search strategies
A comprehensive computer search was conducted in
Pubmed, Embase, Medline, Cochrane Central Register ofControlled Trails (CENTRAL) and ISI Web of Science
for trials published between 1946 and July 2016, using the
keywords “BMI” or “body mass index” or “overweight” or
“obese” and “ARDS” or “ALI” or “acute respiratory distress
syndrome” or “acute lung injury”, without limitations on
publication type or language. We also reviewed the refer-
ences listed in each identified article and manually
searched the related articles to identify all eligible studies
and to minimize the potential publication bias.
Inclusion and exclusion criteria
Eligible clinical trials were identified based on the fol-
lowing criteria: (1) the subjects enrolled in each study
included patients with ARDS; (2) patients were divided
into underweight, normal weight, overweight, obese and
morbidly obese, based on BMI; and (3) outcomes
included, but were not limited to, mortality, length of
stay (LOS) in the ICU, LOS in hospital, or mechanical
ventilation (MV)-free days. We excluded studies if they
were performed in animals or in patients who were
under 18 years of age, or if they were published as
reviews or case reports.
Study selection
Two independent investigators performed the study
selection in two phases. They first discarded duplicated
and non-controlled studies by screening titles and ab-
stracts. They then extracted eligible studies by reviewing
full texts in accordance with the previously designed
study inclusion criteria. Any disagreement was solved by
mutual consensus in the presence of a third investigator.
Data extraction
Independently, two data collectors extracted and re-
corded the desired information from each selected study
in a standard form as recommended by Cochrane [15],
which included information on authors, publication year,
study design, country, participants and population, demo-
graphic characteristics (age, gender, etc.), comorbilities
(diabetes mellitus, liver disease, etc.), assessments of dis-
ease (Acute Physiology and Chronic Health Evaluation
(APACHE) III and Simplified Acute Physiologic Score
(SAPS) II), outcome measures, and study results. For any
missing data, corresponding authors were contacted via
email for the full original data. Different opinions between
the two data collectors were resolved by consensus or by
consulting a third investigator.
Statistical analysis
Statistical analysis was accomplished by an independent
statistician using Cochrane systematic review soft-
ware Review Manager (RevMan; Version 5.3.5; The
Nordic Cochrane Centre, The Cochrane Collaboration,
Copenhagen, 2014). We used the Mann-Whitney U test
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nificance as a Z value and P value <0.05; the results
were displayed in forest plots. Continuous variables
were reported as mean and standard derivation (SD),
while dichotomous variables were reported as frequency
and proportion. An initial test for clinical, methodological
and statistical heterogeneity was conducted, and we used
the χ2 test with P < 0.1 and I2 > 50% to indicate signifi-
cance. We also performed sensitivity analysis to substitute
alternative decisions or ranges of values for decisions that
were arbitrary or unclear. A random-effects model was
applied in all outcome analyses regardless of the statistical
heterogeneity. For continuous data we calculated mean
difference (MD) and 95% CI, while for dichotomous
data we calculated odds ratio (OR) and 95% CI. For
the assessment of risk of bias and study quality, we
used the Newcastle-Ottawa quality assessment tool
(Additional file 1) [16].
Results
Initially 4555 records were identified, of which 4544
were extracted from electronic databases and 11 were
extracted from review of reference lists (Fig. 1). By
screening the titles and abstracts, we discarded 4486Fig. 1 Study flow diagramstudies due to duplication (n = 2584), non-ARDS setting
(n = 1815), non-adult study population (n = 6), animal
experiments (n = 13), or non-controlled studies (n = 68).
We searched the full-text articles for the remaining 69
studies, and eventually 5 trials were selected for our final
analysis, as 29 studies did not report related outcomes,
and 35 did not categorize patients as expected.
Study description
Each enrolled trial was approved by the corresponding
institutional ethical committee (Additional file 2). All
five studies examined the effects of BMI on mortality in
adult ICU patients with ARDS. In one study, data on
hospital and ICU mortality were reported [17]. In two
studies, data on ICU mortality were provided [18, 19]. In
the two remaining studies, one study presented data on
90-day mortality and the other reported data on mortality
[20, 21]. Four studies reported ICU and hospital LOS
[17–19, 21], while three studies provided data on MV-
free days [18–20]. Details of each study included in our
analysis, including different types of reporting of mortality,
are summarized in Table 1.
All the five studies included in our analysis were
multicenter studies from the USA [17–21]. BMI was
Table 1 Details of each enrolled study




O’Brien 2006 [17] Retrospective
cohort,
multicenter




1488/1673 (89%) Hospital mortality
Morris 2007 [21] Prospective
cohort,
multicenter





Stapleton 2010 [20] Retrospective,
multicenter




1409/1451 (97%) 90-day mortality
Soto 2012 [19] Retrospective,
multicenter




751/848 (88%) ICU mortality
Gong 2016 [18] Cohort,
multicenter




1795/1995 (90%) ICU mortality
BMI body mass index, ICU intensive care unit
aOutcome measures include: ① mortality; ② length of stay in ICU; ③ length of stay in hospital; ④ mechanical-ventilation-free days; ⑤ duration of mechanical
ventilation; ⑥ organ-failure-free days; ⑦ plasma cytokine level; ⑧ time to death; ⑨ time to acute kidney injury
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[17–21], with BMI calculated upon ICU admission in
four of these studies [17–20] and at hospital admis-
sion in the remaining study [21].
A total of 6268 patients with ARDS were pooled from all
the included trials in our final meta-analysis. The majority
of patients enrolled in the studies were men (51.5–63.3%),
and the mean age ranged from 49.3 to 65.3 years. Details
of patients’ baseline characteristics in each study included
in the analysis are shown in Table 2.
Quality assessment
The Newcastle-Ottawa scale was used to assess the quality
of individual studies. A maximum of 9 points was assigned
to each study: 4 for selection, 2 for comparability, and 3
for outcomes. A study with a final score ≥6 was regarded
as high quality. Among the five studies, two studies
[17, 21] scored 7 points and three studies [18–20]
scored 6 points, indicating a high risk of bias (Fig. 2).
Heterogeneity
There was statistical heterogeneity between normal
weight and overweight patients in ICU LOS (I2 = 71%,
χ2 = 10.27, P = 0.02), but not between normal weight and
underweight patients or between obese and morbidly
obese patients. For MV-free days, there was only statistical
heterogeneity between normal weight and underweight
patients (I2 = 89%, χ2 = 18.45, P < 0.0001). There was no
significant heterogeneity in mortality or hospital LOS.
Mortality
The OR of mortality in normal weight, underweight,
overweight, obese, and morbidly obese patients was 1.59
(95% CI 1.22, 2.08), 0.88 (95% CI 0.76, 1.01), 0.68 (95%
CI 0.57, 0.80), and 0.72 (95% CI 0.56, 0.93), respectively.
There were significant differences among underweight,
obese, and morbidly obese patients (Z = 3.42, P = 0.0006;Z = 4.68, P < 0.00001; Z = 2.56, P = 0.01), but not over-
weight patients (Z = 1.78, P = 0.08) (Fig. 3).
MV-free days
Compared with normal weight patients, the number of
MV-free days was much greater in morbidly obese pa-
tients (MD 2.64, 95% CI 0.60, 4.67, Z = 2.53, P = 0.01);
but there were no significant differences between normal
weight and underweight (MD -5.85, 95% CI -13.01, 1.31,
Z = 1.60, P = 0.11), overweight (MD -0.29, 95% CI -1.66,
1.07, Z = 0.42, P = 0.67), obese patients (MD 0.79, 95%
CI -0.44, 2.03, Z = 1.26, P = 0.21) (Fig. 4).
ICU and hospital LOS
There were no significant differences between normal
weight and underweight (MD -0.33, 95% CI -1.96, 1.31,
Z = 0.39, P = 0.70), overweight (MD -0.92, 95% CI -2.75,
0.91, Z = 0.98, P = 0.32), obese (MD -0.06, 95% CI -1.37,
1.25, Z = 0.09, P = 0.92), or morbidly obese patients (MD
1.58, 95% CI -0.20, 3.35, Z = 1.74, P = 0.08) (Fig. 5). A
similar pattern was seen in hospital LOS among different
BMI groups (Fig. 6).
Discussion
In our meta-analysis, we found that mortality was likely
to lower among underweight patients with ARDS. More-
over, MV days were fewer in patients who were morbidly
obese. Nevertheless, ICU and hospital LOS were not
shorter in morbidly obese patients, or in obese, over-
weight or underweight patients.
It has been demonstrated that greater mortality in
critically ill patients is associated with various clinical
measurements and different severity of disease, such
as older age, higher APACHE II scores, burden of co-
morbidity, and requirement for vasopressors [22–29].
In our meta-analysis, we noticed that morbidly obese
patients had lower mortality. Previous studies report
Table 2 Baseline characteristics of patients in each trial included in the analysis
















O’Brien 2006 [17] Underweight 62.4 (16.2) 41 (46.6%) NR 0.53 (0.29) 10 (11.4%) NR NR
Normal 61.0 (17.8) 307 (56.4%) 0.58 (0.28) 87 (16.0%)
Overweight 59.4 (16.7) 223 (55.9%) 0.59 (0.29) 98 (24.6%)
Obese 58.0 (16.3) 152 (46.6%) 0.59 (0.28) 113 (34.7%)
Morbidly obese 53.6 (14.9) 44 (33.6%) 0.68 (0.29) 52 (39.7%)
Morris 2007 [21] Underweight 64.7 (18.4) 28 (56.0%) 82.3 (31.5) NR NR NR NR
Normal 61.5 (18.1) 195 (64.8%) 74.9 (29.2)
Overweight 58.9 (17.4) 157 (66.2%) 74.9 (30.0)
Obese 57.0 (15.9) 116 (63.4%) 70.3 (29.8)
Morbidly obese 54.7 (13.9) 26 (48.1%) 75.0 (35.1)
Stapleton 2010 [20] Underweight 50.2 (16.8) 36 (59.0%) 97.2 (35.2) NR 8 (13.1%) NR NR
Normal 51.6 (17.9) 316 (58.3%) 89.9 (29.8) 64 (11.8)
Overweight 52.1 (18.3) 267 (64.0%) 87.2 (30.1) 55 (13.2%)
Obese 51.0 (15.5) 172 (54.6%) 83.7 (30.5) 55 (17.5%)
Morbidly obese 49.3 (13.1) 23 (31.1%) 81.5 (28.6) 26 (35.1%)
Soto 2012 [19] Underweight 65.3 (17.5) 12 (49.0%) 80.9 (20.1) NR 2 (6.0%) 3 (10.0%) 19 (68.0%)
Normal 58.8 (18.8) 147 (63.0%) 75.4 (22.5) 23 (10.0%) 18 (8.0%) 142 (71.0%)
Overweight 59.0 (18.7) 164 (69.0%) 75.7 (25.7) 45 (19.0%) 10 (4.0%) 127 (66.0%)
Obese 56.7 (16.9) 124 (66.0%) 70.4 (21.1) 50 (27.0%) 14 (7.0%) 107 (66.0%)
Morbidly obese 50.2 (13.9) 26 (43.0%) 69.1 (21.3) 29 (45.0%) 5 (8.0%) 43 (61.0%)
Gong 2016 [18] Underweight 61 (20.0) 35 (42.0%) 70 (22.0) NR 14 (17.0%) 3 (4.0%) NR
Normal 63 (18.0) 393 (63.0%) 70 (23.0) 113 (18.0%) 40 (6.0%)
Overweight 62 (17.0) 421 (70.0%) 69 (24.0) 144 (24.0%) 31 (5.0%)
Obese 60 (17.0) 209 (57.0%) 68 (22.0) 140 (38.0%) 17 (5.0%)
Morbidly obese 54 (14.0) 58 (50.0%) 67 (25.0) 52 (45.0%) 8 (7.0%)
BMI body mass index, APACHE Acute Physiology and Chronic Health Evaluation, NR not reported, SAPS Simplified Acute Physiologic Score
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because of their younger age, lower APACHE III and
SAPS II scores, higher arterial partial pressure of oxygen
(PaO2)/fraction of inspired oxygen (FiO2) ratio, and lower
levels of pro-inflammatory cytokines [19, 30]. Further-
more, the increased use of heparin prophylaxis among
patients in the higher BMI categories mediated some pro-
tective effects for obesity and morbid obesity, such asFig. 2 Risk of bias summary. F/U follow upinhibiting the coagulation phenomena to block systemic
inflammatory response [21, 31]. Interestingly, hyperten-
sion, which is prevalent in obese and morbidly obese
patients, was suspected to exert protective hemodynamic
effects during circulatory failure and decrease the need for
fluid or vasopressor support [32]. Therefore, the fact that
higher BMI is a protective factor in ARDS may be reason-
able. In addition, in our analysis being overweight was not
Fig. 3 Effect of body mass index (BMI) on mortality. CI confidence interval, SD standard deviation
Fig. 4 Effect of body mass index (BMI) on mechanical ventilation (MV)-free days. CI confidence interval, SD standard deviation
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Fig. 5 Effect of body mass index (BMI) on ICU length of stay (LOS). CI confidence interval, SD standard deviation
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be attributed to the significant statistical heterogeneity;
however, further evidence and studies are still warranted.
Similarly, morbidly obese patients had shorter duration
of MV in our analysis, which may be partially explainedFig. 6 Effect of body mass index (BMI) on hospital length of stay (LOS). CI cby less severe disease in patients with higher BMI. On the
other hand, from the perspective of respiratory mechanics,
a greater portion of the airway pressure might be allocated
to distend the chest wall during inflation in patients with a
higher BMI [33], thus decreasing the transpulmonaryonfidence interval, SD standard deviation
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injury will be diminished, which is further emphasized by
the lower alveolar pressure due to significant smaller end-
expiratory lung gas volume [34]. Moreover, it is believed
that a substantial amount of lung is still hyperinflated
despite a “protective” tidal volume, and a further reduc-
tion in tidal volume may be beneficial.
O’Brien reported that morbidly obese patients were
often ventilated with significantly higher tidal volume
based on the predicted body weight compared with
patients of normal body weight, and that the need for
greater tidal volume might not be physiological [35]. If
the tidal volume is standardized by an identical study
protocol, morbidly obese patients will receive the same
tidal volume as the normal weight patients, but such a
tidal volume is relatively smaller than that calculated by
the individually predicted body weight. Accordingly,
extra lower ventilation is applied as compared with that
recommended by “lung protective ventilation”, which is
termed as “ultraprotective ventilation” [36].
Nevertheless, we did not identify such a protective role
of being overweight or obese in reducing the number of
MV-free days, which seemed to be paradoxical and
unaccountable. The effect of obesity on the duration of
MV has been controversial in previous studies [37–40]. In
clinical practice physicians need to be cautious in weaning
overweight and obese patients off MV, especially in the ab-
sence of standardized weaning protocols, because of the
perception that these patients are at a higher risk of failure
compared with normal weight patients, which eventually
results in delayed weaning and prolonged MV [21].
There was no significant association between BMI and
ICU or hospital LOS, even though days of MV were
fewer and mortality lower in morbidly obese patients. It
is undeniable that medical resources and expenditure
are tightly related to disease outcomes, such as bed
availability in general wards and insurance status, which
to some extent may offset the positive effects of higher
BMI. However, the results in our study should be inter-
preted cautiously due to the potential significant statistical
heterogeneity. For this reason, more studies focusing on
this issue are necessary to draw a definite conclusion.
We think that the high heterogeneity between the over-
weight and normal weight group in ICU LOS may have
resulted from (1) variation in BMI at different time points.
Among the five studies included, Morris and colleagues
estimated patients’ BMI upon hospital admission, while in
the other four studies it was assessed upon ICU admis-
sion. The gap in between might have potentially affected
the BMI categories, due for example, to fluid resuscitation
treatment, and (2) the heterogeneous population. The
proportion of overweight male patients was smaller than
the proportion of normal weight patients in our included
studies, except for the studies by Morris and Soto. Interms of the high heterogeneity between underweight and
normal weight patients in the number of MV-free days,
the different PaO2/PaCO2 in individual studies might have
contributed to the heterogeneity. In the study of Stapleton,
there was a higher PaO2/PaCO2 in the underweight
compared with the normal weight group. By contrast, the
PaO2/PaCO2 ratio was significantly lower in the under-
weight group in the other studies.
Our study has four limitations that need to be
addressed. First, the rates of missing data in the studies
included were relatively high (3–33%), which may have
influenced the accuracy of our results. Second, BMI was
partly calculated on the basis of physician-estimated or
patient-reported weight and height, especially in the retro-
spective studies; this may be biased by the resuscitation
fluids given prior to ICU admission, which may in turn
affect patient classification. Third, there was significant
statistical heterogeneity in some outcomes, complicated
by a lack of risk adjustment for differences in patients, in
variables such as age, sex, severity of disease (which could
be seen from the APACHE III scores, SAPS scores and
the value of oxygenation index), comorbid illness (such as
diabetes mellitus), smoking, MV parameters, and inter-
action of outcome parameters. This would limit the gen-
eral application of our findings.
We planned to report adjusted data when we designed
our study but were unable to do so. This was because
the adjusted OR and 95% CI, which are indispensable
for performing meta-analysis, were only provided in one
study and we did not have access to the raw data. More-
over, two of the studies included only reported ICU mor-
tality, which may lead to underestimation of mortality
because the patients may have died in the general ward
after leaving the ICU, or might have been readmitted to
the ICU and died during this process. Finally, none of the
studies described whether treatment strategies were
standardized, which may further result in bias.
Conclusions
In patients with ARDS, obesity and morbid obesity
are associated with lower mortality, which can be
considered as protective factors in ARDS/ALI. There
is a need for more large studies, in particular pro-
spective studies designed with identically defined
treatment protocols, and with BMI and other demo-
graphic and clinical information reported in all pa-
tients, to further determine the precise roles of BMI
in patients with ARDS.Additional files
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